Repligen (RGEN) Fails to deliver data

Key failure to deliver metrics for Repligen :

• Last SEC data release: 2025-03-14
• Last 15 days FTD volume: €1.35 M
• Last 3 months FTD volume: €6.38 M
• Last year FTD volume: €6.38 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Repligen (RGEN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Repligen (RGEN) - since 2013

Repligen (RGEN) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Novavax NVAX	€7.68 M	€0.12 B	🇺🇸 USA
BioMarin Pharmaceutical BMRN	€1.7 M	€23.6 M	🇺🇸 USA
Neurocrine Biosciences NBIX	€7.92 M	€16.82 M	🇺🇸 USA
General Electric GE	€0.28 B	€1.23 B	🇺🇸 USA
Thermo Fisher Scientific TMO	€18.45 M	€0.14 B	🇺🇸 USA
Bristol-Myers Squibb BMY	€0.18 B	€0.50 B	🇺🇸 USA
Pfizer PFE	€32.79 M	€0.34 B	🇺🇸 USA
Bio-Techne TECH	€0.56 M	€17.99 M	🇺🇸 USA
Sangamo Therapeutics SGMO	€1.06 M	€6.39 M	🇺🇸 USA
Charles River Laboratories CRL	€9.64 M	€51.1 M	🇺🇸 USA